Braskem S.A. (BRKM3) - Net Assets
Based on the latest financial reports, Braskem S.A. (BRKM3) has net assets worth R$-3.17 Billion BRL (≈ $-622.60 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (R$87.38 Billion ≈ $17.15 Billion USD) and total liabilities (R$90.56 Billion ≈ $17.77 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BRKM3 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | R$-3.17 Billion |
| % of Total Assets | -3.63% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -552.46% |
| Growth Volatility | 91.01 |
Braskem S.A. - Net Assets Trend (1998–2024)
This chart illustrates how Braskem S.A.'s net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Braskem S.A. for the complete picture of this company's asset base.
Annual Net Assets for Braskem S.A. (1998–2024)
The table below shows the annual net assets of Braskem S.A. from 1998 to 2024. For live valuation and market cap data, see BRKM3 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | R$-4.28 Billion ≈ $-839.42 Million |
-230.47% |
| 2023-12-31 | R$3.28 Billion ≈ $643.40 Million |
-46.32% |
| 2022-12-31 | R$6.11 Billion ≈ $1.20 Billion |
-1.54% |
| 2021-12-31 | R$6.20 Billion ≈ $1.22 Billion |
+260.45% |
| 2020-12-31 | R$-3.87 Billion ≈ $-758.68 Million |
-198.02% |
| 2019-12-31 | R$3.94 Billion ≈ $774.02 Million |
-30.24% |
| 2018-12-31 | R$5.65 Billion ≈ $1.11 Billion |
+3.32% |
| 2017-12-31 | R$5.47 Billion ≈ $1.07 Billion |
+218.05% |
| 2016-12-31 | R$1.72 Billion ≈ $337.63 Million |
+81.99% |
| 2015-12-31 | R$945.49 Million ≈ $185.52 Million |
-83.11% |
| 2014-12-31 | R$5.60 Billion ≈ $1.10 Billion |
-25.77% |
| 2013-12-31 | R$7.54 Billion ≈ $1.48 Billion |
-12.86% |
| 2012-12-31 | R$8.65 Billion ≈ $1.70 Billion |
-13.31% |
| 2011-12-31 | R$9.98 Billion ≈ $1.96 Billion |
-4.12% |
| 2010-12-31 | R$10.41 Billion ≈ $2.04 Billion |
+126.64% |
| 2009-12-31 | R$4.59 Billion ≈ $901.13 Million |
+24.80% |
| 2008-12-31 | R$3.68 Billion ≈ $722.04 Million |
-41.37% |
| 2007-12-31 | R$6.28 Billion ≈ $1.23 Billion |
+45.18% |
| 2006-12-31 | R$4.32 Billion ≈ $848.30 Million |
-7.11% |
| 2005-12-31 | R$4.65 Billion ≈ $913.22 Million |
+6.07% |
| 2004-12-31 | R$4.39 Billion ≈ $861.00 Million |
+65.20% |
| 2003-12-31 | R$2.66 Billion ≈ $521.20 Million |
+396.59% |
| 2002-12-31 | R$-895.57 Million ≈ $-175.73 Million |
-135.32% |
| 2001-12-31 | R$2.54 Billion ≈ $497.51 Million |
+9.64% |
| 2000-12-31 | R$2.31 Billion ≈ $453.74 Million |
+9.19% |
| 1999-12-31 | R$2.12 Billion ≈ $415.57 Million |
+11.02% |
| 1998-12-31 | R$1.91 Billion ≈ $374.33 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Braskem S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 920.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | R$8.04 Billion | % |
| Other Comprehensive Income | R$1.70 Billion | % |
| Total Equity | R$-4.78 Billion | 100.00% |
Braskem S.A. Competitors by Market Cap
The table below lists competitors of Braskem S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
W olf Photoelectric Technology Ltd
SHE:002962
|
$702.94 Million |
|
Lloyds Banking Group PLC
LSE:LLOY
|
$703.30 Million |
|
Anterix Inc
NASDAQ:ATEX
|
$703.61 Million |
|
Shanghai Allied Industrial Corp. Ltd. A
SHE:301419
|
$703.80 Million |
|
Hippo Holdings Inc
NYSE:HIPO
|
$702.54 Million |
|
Thinking Electronic Industrial Co Ltd
TW:2428
|
$702.31 Million |
|
Hubei Biocause Heilen Pharmaceutical Co. Ltd.
SHE:301211
|
$702.13 Million |
|
Lg Electronics Pref
KO:066575
|
$702.10 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Braskem S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,992,000,000 to -4,782,000,000, a change of -8,774,000,000 (-219.8%).
- Net loss of 11,320,000,000 reduced equity.
- Dividend payments of 6,000,000 reduced retained earnings.
- Other comprehensive income increased equity by 3,010,000,000.
- Other factors decreased equity by 458,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | R$-11.32 Billion | -236.72% |
| Dividends Paid | R$6.00 Million | -0.13% |
| Other Comprehensive Income | R$3.01 Billion | +62.94% |
| Other Changes | R$-458.00 Million | -9.58% |
| Total Change | R$- | -219.79% |
Book Value vs Market Value Analysis
This analysis compares Braskem S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | R$14.90 | R$7.93 | x |
| 1999-12-31 | R$20.34 | R$7.93 | x |
| 2000-12-31 | R$32.02 | R$7.93 | x |
| 2001-12-31 | R$31.22 | R$7.93 | x |
| 2002-12-31 | R$-4.81 | R$7.93 | x |
| 2003-12-31 | R$6.83 | R$7.93 | x |
| 2004-12-31 | R$11.56 | R$7.93 | x |
| 2005-12-31 | R$12.50 | R$7.93 | x |
| 2006-12-31 | R$11.61 | R$7.93 | x |
| 2007-12-31 | R$13.12 | R$7.93 | x |
| 2008-12-31 | R$7.25 | R$7.93 | x |
| 2009-12-31 | R$8.92 | R$7.93 | x |
| 2010-12-31 | R$14.52 | R$7.93 | x |
| 2011-12-31 | R$12.23 | R$7.93 | x |
| 2012-12-31 | R$10.76 | R$7.93 | x |
| 2013-12-31 | R$9.30 | R$7.93 | x |
| 2014-12-31 | R$7.21 | R$7.93 | x |
| 2015-12-31 | R$2.05 | R$7.93 | x |
| 2016-12-31 | R$3.44 | R$7.93 | x |
| 2017-12-31 | R$7.91 | R$7.93 | x |
| 2018-12-31 | R$8.20 | R$7.93 | x |
| 2019-12-31 | R$6.14 | R$7.93 | x |
| 2020-12-31 | R$-2.77 | R$7.93 | x |
| 2021-12-31 | R$9.87 | R$7.93 | x |
| 2022-12-31 | R$9.18 | R$7.93 | x |
| 2023-12-31 | R$5.01 | R$7.93 | x |
| 2024-12-31 | R$-6.00 | R$7.93 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Braskem S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -14.62%
- • Asset Turnover: 0.76x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (12.84%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 6.49% | 9.71% | 0.40x | 1.66x | R$-66.00 Million |
| 1999 | 10.18% | 11.69% | 0.51x | 1.72x | R$3.83 Million |
| 2000 | 16.05% | 12.09% | 0.81x | 1.63x | R$138.21 Million |
| 2001 | -1.16% | -0.63% | 0.73x | 2.53x | R$-248.49 Million |
| 2002 | 0.00% | -19.24% | 0.81x | 0.00x | R$-1.50 Billion |
| 2003 | 10.18% | 2.12% | 0.73x | 6.57x | R$3.83 Million |
| 2004 | 16.51% | 5.67% | 0.81x | 3.60x | R$272.60 Million |
| 2005 | 13.80% | 4.79% | 0.84x | 3.44x | R$172.11 Million |
| 2006 | 2.35% | 0.78% | 0.80x | 3.78x | R$-329.09 Million |
| 2007 | 9.64% | 3.10% | 0.85x | 3.66x | R$-20.30 Million |
| 2008 | -67.72% | -13.88% | 0.79x | 6.17x | R$-2.86 Billion |
| 2009 | 19.97% | 6.02% | 0.69x | 4.83x | R$457.98 Million |
| 2010 | 18.24% | 7.43% | 0.74x | 3.32x | R$856.29 Million |
| 2011 | -5.38% | -1.58% | 0.89x | 3.83x | R$-1.50 Billion |
| 2012 | -8.54% | -2.06% | 0.86x | 4.81x | R$-1.59 Billion |
| 2013 | 6.89% | 1.24% | 0.87x | 6.33x | R$-230.57 Million |
| 2014 | 15.05% | 1.88% | 0.93x | 8.62x | R$289.90 Million |
| 2015 | 192.61% | 6.64% | 0.78x | 37.19x | R$2.98 Billion |
| 2016 | -15.02% | -0.86% | 0.92x | 18.92x | R$-685.33 Million |
| 2017 | 64.81% | 8.29% | 0.93x | 8.37x | R$3.45 Billion |
| 2018 | 43.89% | 4.94% | 0.99x | 9.00x | R$2.21 Billion |
| 2019 | -54.05% | -5.05% | 0.77x | 13.95x | R$-3.13 Billion |
| 2020 | 0.00% | -11.98% | 0.68x | 0.00x | R$-6.80 Billion |
| 2021 | 177.79% | 13.24% | 1.14x | 11.77x | R$13.20 Billion |
| 2022 | -11.20% | -0.85% | 1.10x | 12.03x | R$-1.55 Billion |
| 2023 | -114.70% | -6.49% | 0.77x | 22.98x | R$-4.98 Billion |
| 2024 | 0.00% | -14.62% | 0.76x | 0.00x | R$-10.84 Billion |
Industry Comparison
This section compares Braskem S.A.'s net assets metrics with peer companies in the Chemicals industry.
Industry Context
- Industry: Chemicals
- Average net assets among peers: $1,217,196,500
- Average return on equity (ROE) among peers: 13.43%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Braskem S.A. (BRKM3) | R$-3.17 Billion | 6.49% | N/A | $702.80 Million |
| Dexxos Participações S.A (DEXP3) | $951.17 Million | 15.16% | 0.64x | $147.43 Million |
| Unipar Carbocloro S.A (UNIP3) | $1.48 Billion | 11.70% | 1.51x | $459.36 Million |
About Braskem S.A.
Braskem S.A., together with its subsidiaries, engages in the manufacture, sale, import, and export of chemicals, petrochemicals, and fuels in Brazil. It produces and sells polyethylene (PE), polypropylene, tertiary-butyl ethyl ether, gasoline, benzene, toluene, xylene, ethylene, propylene, polyvinyl chloride, caustic soda, butadiene, cumene, naphtha, solvents, and condensate; thermoplastic resins… Read more